Skip navigation

The Impact of a Human Papillomavirus (HPV) Vaccination Campaign on Routine Primary Health Service Provision and Health Workers in Tanzania: A Controlled Before and After Study

The Impact of a Human Papillomavirus (HPV) Vaccination Campaign on Routine Primary Health Service Provision and Health Workers in Tanzania: A Controlled Before and After Study

Author: 
Katherine E. Gallagher
Tusajigwe Erio
Kathy Baisley
Shelley Lees
Deborah Watson-Jones
Publication Date
Monday, March 12, 2018
Affiliation: 

London School of Hygiene and Tropical Medicine (Gallagher, Baisley, Lees, Watson-Jones); Mwanza Intervention Trials Unit, National Institute for Medical Research (Gallagher, Erio, Watson-Jones)

Resource-poor countries carry over 85% of the disease burden of cervical cancer, 70% of the cases of which can be prevented by two human papillomavirus (HPV) vaccines that have been described as widely licensed, safe, and efficacious. In 2014, the Tanzanian Ministry of Health and Social Welfare (MoHSW) began a Gavi-supported HPV vaccine demonstration project using school-based delivery in Kilimanjaro region, northern Tanzania. Yet introducing a multi-dose vaccine such as the HPV vaccine to a novel population that requires outreach activities and careful community mobilisation could potentially stress under-resourced health systems and affect the delivery of other services.

  <div class="field button"><a href="https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-018-2976-2" target="_blank">Click here to read the article online or to download it in PDF format (10 pages).</a></div>
Contacts (user reference): 
Source: 

BMC Health Services Research (2018) 18:173. https://doi.org/10.1186/s12913-018-2976-2. Image credit: Merck Responsibilty

read more

The Media Development Network